Heartflow, Inc. (HTFL): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$5.44M

Year ended 2025-12-31

$5.32M

Trailing 12 months to 2026-06-30

2023-12-31 Depreciation & Amortization (USD) 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$5.44M	+1.5%	2026-03-18, From 2025-01-01
2024-12-31	$5.36M	+12.9%	2026-03-18, From 2024-01-01
2023-12-31	$4.74M	n/a	2026-03-18, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Heartflow, Inc. (HTFL)	2025-12-31	$5.44M	+1.5%
SI-BONE, Inc. (SIBN)	2025-12-31	$5.77M	+31.8%
Neuronetics, Inc. (STIM)	2025-12-31	$3.46M	+67.1%
Treace Medical Concepts, Inc. (TMCI)	2025-12-31	$10.62M	+26.2%
InfuSystem Holdings, Inc (INFU)	2025-12-31	$13.29M	+6.4%
Xtant Medical Holdings, Inc. (XTNT)	2025-12-31	$5.22M	+23.7%
Cerus Corp (CERS)	2025-12-31	$1.43M	-23.1%
Orthopediatrics Corp (KIDS)	2025-12-31	$21.12M	+10.7%
Lemaitre Vascular Inc (LMAT)	2025-12-31	$10.42M	+8.4%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗